Purchases and Sales Made in Q4 2023 in Ptc Therapeutics, Inc. (PTCT)
This table provides information about the institutional ownership of Ptc Therapeutics, Inc. (PTCT) during Q4 2023. The information is specifically focused on institutions that hold shares of PTC THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-191K- 41.84% |
$3.46M - $5.62M
|
266K
$13.3M
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-270K- 17.83% |
$4.89M - $7.94M
|
1.25M
$62.3M
|
|
|
Feb 14, 2024
Q4 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-460K- 14.96% |
$8.31M - $13.5M
|
2.61M
$131M
|
|
|
Feb 14, 2024
Q4 2023
|
Man Group PLC
London, X0 |
SELL
|
- |
-514K- 98.15% |
$9.29M - $15.1M
|
9.7K
$485K
|
|
|
Feb 14, 2024
Q4 2023
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-562K- 88.44% |
$10.2M - $16.5M
|
73.5K
$3.68M
|
|
|
Feb 09, 2024
Q4 2023
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-631K- 30.67% |
$11.4M - $18.5M
|
1.43M
$71.3M
|
|
|
Feb 14, 2024
Q4 2023
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-1.73M- 99.91% |
$31.3M - $50.8M
|
1.58K
$79.1K
|